PARADEEP NSE filing

Paradeep Phosphates Board Approves FY26 Results, Recommends Dividend

The RealCase readMedium impact Positive

Paradeep Phosphates Limited announced its audited standalone and consolidated financial results for FY26. The Board approved a dividend of ₹1.50 per equity share, subject to member approval at the AGM. Mrs. Rita Menon was re-appointed as an Independent Director for a three-year term from June 27, 2026.

Why it matters

The announcement includes the approval of financial results and a dividend recommendation, which are material events for shareholders. The re-appointment of a director also has a moderate impact on corporate governance.

The market read

The company reported its financial results and recommended a dividend, which is generally viewed positively by investors. The re-appointment of an independent director also indicates stability.

Paradeep Phosphates Limited (PPL) announced the outcome of its Board Meeting held on May 11, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.

The company recommended a dividend of ₹1.50 per equity share of ₹10 each for the financial year ended March 31, 2026. This dividend is subject to the approval of the members at the upcoming Annual General Meeting (AGM).

Furthermore, the Board approved the re-appointment of Mrs. Rita Menon as an Independent Director for a second term of three years, effective June 27, 2026, pending shareholder approval. The company also confirmed that Mrs. Rita Menon has not been debarred from holding the office of Director by any SEBI order or other authority.

The audited standalone and consolidated financial results for the fiscal year ended March 31, 2026, were issued with an unmodified opinion by the statutory auditors, M/s. BSR & Co. LLP. The meeting commenced at 3:00 PM IST and concluded at 5:30 PM IST.

Filing to action

What to do with a filing like this

Paradeep Phosphates Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Paradeep Phosphates Limited. Read the original for the full detail.

View original filing